Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
Status:
Completed
Trial end date:
2006-08-07
Target enrollment:
Participant gender:
Summary
This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg
kit product for the treatment of migraine or cluster headache attacks in clinical settings,
to demonstrate the efficacy, and to examine patient acceptability (simplicity and usefulness)
and rate of successful self-injection.